Category: Pharma Industry

Exclusive

Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

J&J said its 340B rebate proposal will apply to Arkansas covered entities.

Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Another Drug Industry Setback, Maryland Federal Judge Rejects Bids to Block State’s 340B Contract Pharmacy Access Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

A federal district judge in Maryland denied multiple drug industry motions in a contract pharmacy lawsuit.

A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Asks D.C. Federal Court to Rule for Drugmakers in Contract Pharmacy Lawsuits, Ties Outcomes to Kalderos 340B Rebate Case

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

HHS filed status reports in five separate ongoing drug industry cases before a federal district court.

The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Maryland, Missouri, West Virginia

September 6, 2024 340B Report Staff Views

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

Beacon Channel Management is holding multiple trainings on its 340B rebate platform.

The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

September 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.

German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Relents on Arkansas Contract Pharmacy Law; AbbVie Exempts MO, MS Covered Entities

September 4, 2024 Shannon Young and Bella Czajkowski, Associate Editor/Senior Writer Views

Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.

Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.

Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions

September 3, 2024 Shannon Young, Associate Editor/Senior Writer Views

Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.

A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live